Shared on 05 Nov 25
Fair value Decreased 0.66%Light & Wonder's analyst price target was revised downward to $105.85 from $106.55, as analysts cite increased challenges to meeting core EBITDA targets along with concerns over future cash flow and leverage. Analyst Commentary Bullish Takeaways The revised fiscal 2025 EBITDA guidance points to growth, particularly with the inclusion of Grover.
Shared on 22 Oct 25
Fair value Decreased 1.67%Analysts have lowered their price target for Light & Wonder from $108 to $95. They cite uncertainty around core business growth and future cash flow challenges as key factors influencing their revised outlook.
Shared on 04 Sep 25
Light & Wonder’s unchanged consensus price target of $108.36 reflects a balance of bearish concerns over the achievability of revised EBITDA targets and free cash flow headwinds, offset by bullish confidence in the core business and limited legal risk from ongoing litigation. Analyst Commentary Bearish analysts lowered their price targets due to concerns that Light & Wonder’s revised fiscal 2025 EBITDA guidance now includes Grover, making it more difficult to achieve the company’s original $1.4B EBITDA target.
Shared on 30 Apr 25
Fair value Decreased 0.43%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 23 Apr 25
Fair value Increased 1.07%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Increased 1.45%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Decreased 1.37%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 0.67%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 0.20%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Increased 3.85%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 10 Mar 25
Fair value Decreased 1.25%AnalystConsensusTarget made no meaningful changes to valuation assumptions.

